AzTrials
AzTrials

SurvivorshipNCT05620979

Financial Navigation Study Among Young Adult Blood Cancer Survivors

A study testing Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation. in people with Survivorship and Cancer, run by Tufts Medical Center at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview. Read more about this study

Who is it for?
Ages 18 to 39 years
Conditions the study is for
Survivorship, Cancer, Financial Stress
What is being tested?
Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
5 sitesUnited States
Study dates
14 Feb 2022to 23 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm)
  • Current age between 18-39 years old
  • Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood (18-36 years of age)
  • At least three years post blood cancer diagnosis
  • Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer medication with stable disease
  • Off treatment for a second cancer (non-blood cancer) or on a stable long-term regimen, such as hormone therapy or hormone replacement therapy
  • Primary residence in United States
  • Able to understand and read the English language

Who cannot join

  • On parent or guardian's insurance

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites

  • Tufts Medical Center

    Boston, Massachusetts, 02111

  • Bon Secours Mercy Health System

    Greenville, South Carolina, 29607

  • MD Anderson

    Houston, Texas, 77030

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027

  • University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital)

    Los Angeles, California, 90033

Other trials in United States

About this study

Official title: Evaluating the Role of Financial Navigation in Alleviating Financial Distress Among Young Adult Survivors of Blood Cancer

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

Read the detailed description

This fully remote, multi-site study will evaluate the role of financial navigators in relieving financial distress in young adults (18-39y) who have completed treatment for blood cancer at least three years ago. Serial Assessments at study entry, 3-months, and 6-months measure financial distress measured using the study's primary outcome measure the Personal Financial Wellness Scale™ (PFW) (see below), hypothesized effect modifiers (emotional distress, self-efficacy, cognitive functioning), as well as care seeking, household finances and insurance characteristics. Randomization will occur following completion of baseline measures (see below for description of study arms). In addition to a formal evaluation of the intervention at 3- and 6-months, an optional interview will occur following the 6-month assessment/navigation intervention period to gain further insight from participants about the acceptability of the intervention. For ethical considerations related to the topic of study, all participants will be provided with the Leukemia \& Lymphoma Society's information specialist hotline.

Being tested
Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
Medical subject headings
Neoplasms, Financial Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.Behavioural

    Providing financial navigation to blood cancer survivors.

Study groups in NCT05620979
Study groupRoleWhat they receive
Active NavigationActive comparatorActive navigation with the study-based financial navigator scheduling four check-in meetings throughout the study with the participant. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Receives: Behavioral: Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
Ad Hoc NavigationActive comparatorAd hoc navigation in which participant is provided study-based financial navigator to contact as needed. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Receives: Behavioral: Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
No study-based NavigationActive comparatorNo access to a study-based financial navigator, but access to a national hotline through the Leukemia \& Lymphoma Society. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Receives: Behavioral: Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Personal Financial Wellness Scale (PFW)

    To evaluate the change in financial distress associated with randomization group assignment from baseline to 6-month follow up as measured by the 8-item Personal Financial Wellness Scale (PFW). The PFW scores range from 1-10 where lower scores indicate greater financial distress.

    Measured: 6 months

Secondary outcomes (1)

  1. Health-Related Quality of Life (HrQoL) Measures

    As part of Aim 1, we will explore whether changes in financial distress (baseline to 6-months) are moderated by emotional distress, self-efficacy, and cognitive functioning, as measured by Patient-Reported Measurement Information System (PROMIS) 4-item short forms for emotions distress (depression and anxiety) and self-efficacy, as well as the 4-item cognitive functioning scale from the Quality of Life in Neurological Disorders (Neuro-Qol) battery. For each of these short forms, high scores connote better functioning.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2022
  2. Study start14 Feb 2022
  3. Primary completion6 Nov 2023
  4. Study completion23 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Single group
Model description
This is a multi-site, three-arm, financial navigation intervention
Masking
None (open label)
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05620979
Sponsor's protocol ID
STUDY00001828
Status last verified
Nov 2024
First submitted
31 Oct 2022
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ohlsen TJD, Murphy-Banks R, Beauchemin MP, Rodday AM, Freyer DR, Miller KA, Fleisher E, Xiang Q, Linendoll N, Chan RY, Crosswell HE, Roth ME, Parsons SK. Cancer-Related Impacts on Employment and Strategies for Support Among Long-Term Young Adult Survivors of Hematologic Malignancies. JCO Oncol Pract. 2025 Dec 12:OP2500558. doi: 10.1200/OP-25-00558. Online ahead of print.

    PubMed 41385752

  • Beauchemin MP, Murphy-Banks R, Rodday AM, Freyer DR, Miller KA, Fleisher E, Ohlsen TJD, Linendoll N, Chan RY, Crosswell HE, Roth ME, Parsons SK. Factors influencing engagement in survivorship care among young adult survivors of hematologic malignancies: a mixed methods report. Support Care Cancer. 2025 Jun 25;33(7):628. doi: 10.1007/s00520-025-09686-1.

    PubMed 40562962

  • Zheng DJ, Murphy-Banks R, Rodday AM, Xiang Q, Linendoll N, Beauchemin M, Ohlsen TJD, Fleisher E, Miller KA, Freyer DR, Crosswell HE, Chan RY, Roth ME, Parsons SK. "Nothing Is as Great a Learning Experience as Getting a $15,000 Bill": A Mixed-Methods Study of Young Adult Cancer Survivors' Experience With Insurance Coverage. JCO Oncol Pract. 2026 Mar;22(3):445-454. doi: 10.1200/OP-24-01075. Epub 2025 Jun 16.

    PubMed 40523211

  • Parsons SK, Murphy-Banks R, Rodday AM, Roth ME, Miller K, Linendoll N, Chan R, Crosswell HE, Xiang Q, Freyer DR. Financial distress and medical financial hardship among young adult survivors of blood cancer. JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae071. doi: 10.1093/jncics/pkae071.

    PubMed 39153000

Questions about this trial

What is this clinical trial studying?

A study testing Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation. in people with Survivorship and Cancer, run by Tufts Medical Center at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Personal Financial Wellness Scale (PFW) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05620979, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in